Evaluation of pulmonary vascular resistance and vasoreactivity testing with oxygen in children with congenital heart disease and pulmonary arterial hypertension

📌 3 Key Takeaways

🎯

Objective & Hypothesis:Evaluation of pulmonary vascular resistance and vasoreactivity testing with oxygen in children with congenital heart disease and pulmonary arterial hypertension

📊

Key Findings & Data:Evaluation of pulmonary vascular resistance and vasoreactivity testing with oxygen in children with congenital heart disease and pulmonary arterial hypertension

💡

Conclusion & Impact:Evaluation of pulmonary vascular resistance and vasoreactivity testing with oxygen in children with congenital heart disease and pulmonary arterial hypertension

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Abstract

Evaluation of pulmonary vascular resistance and vasoreactivity testing with oxygen in children with congenital heart disease and pulmonary arterial hypertension

🔖

Cite This Article

ŞANLI, C., ÇEVİK, A., KULA, S., OLGUNTÜRK, R., TUNAOĞLU, S., OĞUZ, D., SAYLAN, B. (2022). Evaluation of pulmonary vascular resistance and vasoreactivity testing with oxygen in children with congenital heart disease and pulmonary arterial hypertension. Anadolu Kardiyoloji Dergisi, Cilt: 14 - Sayı: 2, 196–198. https://ajindex.com/articles/436090

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (1)

Limsuwan A, Khowsathit P Assessment of pulmonary vasoreactivity. in children with pulmonary hypertension. Curr Opin Pediatr 2009; 21: 594-9. [CrossRef] Hoeper MM, Lee SH, Voswinckel R, Palazzini M, Jais X, Marinelli A. Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol 2006; 48: 2546-52. [CrossRef] Barst RJ, Maislin G, Fishman AP Vasodilator therapy for primary pulmonary. hypertension in children. Circulation 1999; 99: 1197-208. [CrossRef] Houde C, Bohn DJ, Freedom RM. Profile of paediatric patients with pulmonary hypertension judged by responsiveness to vasodilators. Br Heart J 1993; 70: 461-8. [CrossRef] Hill KD, Lim DS, Everett AD, Ivy DD, Moore JD. Assessment of pulmonary hypertension in the pediatric catheterization laboratory: current insights from the Magic registry. Catheter Cardiovasc Interv 2010; 76: 865-73. [CrossRef] Badesch DB, Champion HC, Sanchez MA, Hoeper MM, Loyd JE, Manes A, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2009; 54: 55-66. [CrossRef] Rosenzweig EB, Barst RJ. Clinical Management of Patients with Pulmonary Hypertension. In: Allen HD, Driscoll DJ, Shaddy RE, Feltes TF, (eds). Moss and Adams’s Heart Disease in infants, children, and adolescents. 7th ed. Lippincott Williams&Wilkins Publication; Philadelphia, 2008. p.1355-66. Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009; 34: 1219-63. [CrossRef] Barst RJ, Gibbs JS, Ghofrani HA, Hoeper MM, McLaughlin VV, Rubin LJ, et al. Updated evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol 2009; 54: 78-84. [CrossRef] McLaughlin VM, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension. Circulation 2009; 119: 2250-94. [CrossRef]